12:00 AM
 | 
Aug 14, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

DTI-015 carmustine regulatory update

The FDA granted Orphan Drug designation for Direct's solvent facilitated carmustine perfusion product to...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >